Deep Venous Thrombosis
Successful DVT prophylaxis with pharmacologic agents and adjunctive treatment modalities depends on both consistency and accuracy.
However, "high-dose" formulations increase the risk of DVT and other cardiovascular complications.
Statin therapy after an initial stroke reduces the likelihood of a second stroke and death, a study suggests
Oral rivaroxaban is more effective than subcutaneous enoxaparin for reducing risk of symptomatic deep venous thrombosis (DVT) after total knee arthroplasty.